Join
Live feed
·
PRReleasevia Quantisnow
Editas Medicine Inc. logo

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

ByQuantisnow·Wall Street's wire, on your screen.
EDIT· Editas Medicine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EDIT (Editas Medicine Inc.) and more on Quantisnow.